Regenerative medicine technologies rely heavily on the use of well‐designed biomaterials
for therapeutic applications. The success of implantable biomaterials hinges upon the ability …

The immune system is the key target for vaccines and immunotherapeutic approaches
aimed at blunting infectious diseases, cancer, autoimmunity, and implant rejection …

The immune system has remarkable capabilities to combat disease with exquisite selectivity.
This feature has enabled vaccines that provide protection for decades and, more recently …

The clinical success of cancer immunotherapy is providing exciting opportunities for the
development of new methods to detect and treat cancer more effectively. A new generation …

Vaccines aim to protect against or treat diseases through manipulation of the immune
response, promoting either immunity or tolerance. In the former case, vaccines generate …

Cellular therapies are poised to transform the field of medicine by restoring dysfunctional
tissues and treating various diseases in a dynamic manner not achievable by conventional …

Adaptive immune responses, characterized by T cells and B cells engaging and responding
to specific antigens, can be raised by biomaterials containing proteins, peptides, and other …

Inflammation is an essential component of a wide variety of disease processes and
oftentimes can increase the deleterious effects of a disease. Finding ways to modulate this …

The past decade has witnessed the explosive development of cancer immunotherapies.
Nevertheless, low immunogenicity, limited specificity, poor delivery efficiency, and off‐target …

Stem cell therapy and tissue engineering hold considerable potential for innovative and
transformative strategies to repair damaged tissue form and function. Although many …